Laura A. DeFelice - 14 May 2026 Form 4 Insider Report for CREDIT SUISSE HIGH YIELD CREDIT FUND (DHY)

Reporting relationship: Chair of the Board and Trustee
Issuer ticker: DHY
Reported as of: 14 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 26 May 2026, 08:42:37 UTC
Prior SEC filing: 21 Jan 2025
Source filing: View source filing
Reporting owner signature: /s/Karen Regan, as attorney-in-fact

Key filing fact

Laura A. DeFelice filed Form 4 for CREDIT SUISSE HIGH YIELD CREDIT FUND (DHY) on 26 May 2026.

Key facts

This page summarizes Laura A. DeFelice's Form 4 filing for CREDIT SUISSE HIGH YIELD CREDIT FUND (DHY).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 26 May 2026, 08:42.

Change

Previous filing in this sequence was filed on 21 Jan 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001739194 Primary reporting owner

DeFelice Laura A

Relationship: Chair of the Board and Trustee
Address: C/O 1285 AVENUE OF THE AMERICAS, NEW YORK
Signature: /s/Karen Regan, as attorney-in-fact
Signature date: 26 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DHY transaction

common shares

Other

Transaction value
Shares: +18,933
Change %: +33%
Price: $1.75^*
Shares after: 75,734
Date: 14 May 2026
Ownership: Direct
Footnotes: F1

DHY transaction

common shares

Other

Transaction value
Shares: +20,000
Change %: +26%
Price: $1.75^*
Shares after: 95,734
Date: 14 May 2026
Ownership: Direct
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The transferable rights offering commenced on April 21, 2026 and expired May 14, 2026 (the "Expiration Date"). The subscription price was $1.75 per share and was determined based upon a formula equal to 86% of the net asset value per common share at the close of trading on the NYSE American on the Expiration Date.

Footnote F2

Represents 20,000 shares subscribed for by the Reporting Person pursuant to an over-subscription privilege under the rights offerings.